ViennaLab Diagnostics
BRAF StripAssay®
BRAF Mutation Detection in Human Tumors
The BRAF StripAssay® is an efficient and cost-effective solution to detect BRAF gene mutations, which occur in as many as 8% of human tumors, enabling rapid therapeutic decision-making.
Key Features
01
BRAF Mutation Detection
Detects BRAF gene mutations present in up to 8% of human tumors, enabling targeted therapy decisions.
02
Rapid Results
Fast, cost-effective BRAF mutation analysis to support timely clinical decision-making in oncology settings.
03
Reverse Hybridization
Based on reverse hybridization of biotinylated PCR products for sensitive and specific mutation detection.
04
Minimal Equipment Required
Requires only a thermal cycler and shaking water bath for streamlined lab workflows.
For Research Use Only (RUO)
BRAF StripAssay® is intended for research use only in the United States and is not FDA-cleared for diagnostic use.